Diabetic Macular Edema (DME) Active Not Recruiting Phase 4 Trials for Ranibizumab (DB01270)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03759860Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular EdemaTreatment
NCT02059772Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular EdemaTreatment